NeuroOne Medical Technologies Corp. (NMTC)
1.62
-0.04
(-2.41%)
USD |
NASDAQ |
Sep 04, 16:00
1.64
+0.02
(+1.23%)
After-Hours: 20:00
NeuroOne Medical Technologies Gross Profit Margin (Quarterly) : 59.94% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.94% |
| March 31, 2026 | 53.18% |
| December 31, 2025 | 54.20% |
| September 30, 2025 | 55.77% |
| June 30, 2025 | 53.94% |
| March 31, 2025 | 55.61% |
| December 31, 2024 | 78.53% |
| September 30, 2024 | 51.82% |
| June 30, 2024 | 34.14% |
| March 31, 2024 | 28.35% |
| December 31, 2023 | 27.24% |
| September 30, 2023 | 26.11% |
| June 30, 2023 | 38.69% |
| March 31, 2023 | 6.76% |
| December 31, 2022 | 91.92% |
| September 30, 2022 | 95.83% |
| June 30, 2022 | -111.6% |
| March 31, 2022 | -98.91% |
| December 31, 2021 | -80.80% |
| September 30, 2021 | -22.89% |
| June 30, 2021 | -7.65% |
| March 31, 2021 | -2.60% |
| December 31, 2020 | -16.44% |
| September 30, 2020 | 98.58% |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -122.1% |
| Return on Assets | -84.55% |
| Return on Invested Capital | -117.5% |
| Profit Margin (Quarterly) | -101.7% |
| Operating Margin (Quarterly) | -122.9% |
| Return on Net Operating Assets | -178.9% |